肺癌會議討論：EGFR與ALK突變的重要性辯論Lung Cancer Conference Debate: The Importance of EGFR vs. ALK Mutations

腫瘤科吳教恩醫師
腫瘤科吳教恩醫師
948粉絲
5 次觀看·2026年2月10日

在最近的肺癌會議中，一位肺癌大師分享了自己的寶貴經驗。他指出，許多治療概念並非僅靠臨床試驗就能回答，而是需要透過專家的互享討論來激盪出不同的火花。在這次會議中，我們將深入辯論EGFR和ALK突變的重要性，探討哪一個對於肺癌治療更為關鍵。EGFR突變是否比ALK重要？還是相反？通過這段影片，我們希望為大家提供深入的見解和不同的觀點，幫助更好地理解這兩種突變在肺癌治療中的角色。

At a recent lung cancer conference, a master in the field shared his invaluable experience. He highlighted that many treatment concepts cannot be solely answered by clinical trials but require the sharing and discussion among experts to spark different ideas. In this conference, we delve into a debate on the importance of EGFR vs. ALK mutations, exploring which one is more crucial for lung cancer treatment. Is the EGFR mutation more important than ALK, or is it the opposite? Through this video, we aim to provide in-depth insights and diverse perspectives to help better understand the roles of these two mutations in lung cancer therapy.